Inventor · disambiguated record
Yu Zhou
Also filed as: ZHOU YU · ZHOU YU-DONG
7 granted patents·4 pending applications·13 citations·filing 2004–2025
78Inventor score
Files withLONZA SALES AG3NAT INSTITUTE OF BIOLOGICAL SCIENCES BEIJING2ADLAI NORTYE BIOPHARMA CO LTD1CODIAK BIOSCIENCES INC1NAGLE DALE G1
Top patents by PatentIndex Score
11 records- 0193US10723782B2Exosomes for immuno-oncology and anti-inflammatory therapyCODIAK BIOSCIENCES INC·Filed 2018·Granted Jul 28, 2020·9 cites·19 claims
- 0291US12331100B2Exosomes for immuno-oncology and anti-inflammatory therapyLONZA SALES AG·Filed 2022·Granted Jun 17, 2025·1 cites·20 claims
- 0383US12030924B2Exosomes for immuno-oncology and anti-inflammatory therapyLONZA SALES AG·Filed 2020·Granted Jul 9, 2024·1 cites·18 claims
- 0480US12091398B2PD-L1 antagonist compoundADLAI NORTYE BIOPHARMA CO LTD·Filed 2020·Granted Sep 17, 2024·2 cites·29 claims
- 0577US2025296980A1Exosomes for immuno-oncology and anti-inflammatory therapyLONZA SALES AG·Filed 2025·Application pending·0 cites
- 0655US9845298B15-HT2B antagonistsNAT INSTITUTE OF BIOLOGICAL SCIENCES BEIJING·Filed 2017·Granted Dec 19, 2017·0 cites·20 claims
- 0751US2018111908A15-HT2B AntagonistsNAT INSTITUTE OF BIOLOGICAL SCIENCES BEIJING·Filed 2017·Application pending·0 cites
- 0847US9751845B25-HT2B antagonistsNAT INST OF BIOLOGICAL SCIENCES BEIJING·Filed 2016·Granted Sep 5, 2017·0 cites·20 claims
- 0945US2009137664A1Saururus cernuus compounds that inhibit cellular responses to hypoxiaNAGLE DALE G·Filed 2008·Application pending·0 cites
- 1042US7375132B2Compounds and methods for inhibiting cellular responses to hypoxiaUNIV MISSISSIPPI·Filed 2005·Granted May 20, 2008·0 cites·12 claims
- 1139US2005054720A1Saururus cernuus compounds that inhibit cellular responses to hypoxiaFiled 2004·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yu Zhou files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →